Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common Shares, no par value per share
-
Shares outstanding
-
53,788,752
-
Total 13F shares
-
187,649
-
Share change
-
-1,439
-
Total reported value
-
$888,276
-
Price per share
-
$4.73
-
Number of holders
-
11
-
Value change
-
-$5,906
-
Number of buys
-
1
-
Number of sells
-
4
Institutional Holders of ProMIS Neurosciences Inc. - Common Shares, no par value per share (PMN) as of Q1 2023
As of 31 Mar 2023,
ProMIS Neurosciences Inc. - Common Shares, no par value per share (PMN) was held by
11 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
187,649 shares.
The largest 10 holders included
Northeast Financial Consultants Inc, IEQ CAPITAL, LLC, BANK OF AMERICA CORP /DE/, CLARET ASSET MANAGEMENT Corp, FIDUCIARY TRUST CO, JPMORGAN CHASE & CO, MORGAN STANLEY, Royal Bank of Canada, GABLES CAPITAL MANAGEMENT INC., and NATIONAL BANK OF CANADA /FI/.
This page lists
11
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.